Dr. Carter's research is focused on the analysis of extracellular vesicles (EVs) as potential biomarkers for glioma. Dr. Carter is Professor and Chief of Neurosurgery at the Massachusetts General Hospital. I specialize in intracranial surgery including benign and malignant brain tumors and metastatic brain lesions. My laboratory leads a multi-institutional collaborative effort to clinically validate exRNA biomarkers, including those present in EVs. We also study the role of chimeric T-cell receptors as therapeutics for glioma.